Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01112527
Title PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Henry Ford Hospital, Pfizer
Indications

brain glioblastoma multiforme

glioblastoma

Therapies

Dacomitinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field